Labcorp Holdings Files 8-K
Ticker: LH · Form: 8-K · Filed: Sep 25, 2025 · CIK: 920148
| Field | Detail |
|---|---|
| Company | Labcorp Holdings Inc. (LH) |
| Form Type | 8-K |
| Filed Date | Sep 25, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, disclosure
Related Tickers: LH
TL;DR
Labcorp filed an 8-K on 9/25/25, check for updates.
AI Summary
On September 25, 2025, LABCORP HOLDINGS INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This 8-K filing indicates that Labcorp Holdings is providing updates or disclosures to the SEC, which could contain important information for investors.
Risk Assessment
Risk Level: low — The provided excerpt is a standard 8-K filing notification and does not contain specific material events or financial data that would indicate a change in risk.
Key Players & Entities
- LABCORP HOLDINGS INC. (company) — Registrant
- 0000920148-25-000088 (filing_id) — Accession Number
- September 25, 2025 (date) — Filing Date
- 358 South Main Street, Burlington, North Carolina 27215 (address) — Principal Executive Offices
- 336-229-1127 (phone_number) — Business Phone
FAQ
What is the primary purpose of this 8-K filing?
The filing is primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was this 8-K filed?
The 8-K was filed on September 25, 2025.
What is the exact name of the company filing this report?
The exact name of the company is LABCORP HOLDINGS INC.
Where are LABCORP HOLDINGS INC.'s principal executive offices located?
Their principal executive offices are located at 358 South Main Street, Burlington, North Carolina 27215.
What is the Commission File Number for LABCORP HOLDINGS INC.?
The Commission File Number is 1-11353.
Filing Stats: 483 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2025-09-25 16:29:14
Key Financial Figures
- $0.10 — ange on which registered Common Stock, $0.10 par value LH New York Stock Exchange
Filing Documents
- lh-20250925.htm (8-K) — 26KB
- formpr3q25ex991earningsann.htm (EX-99.1) — 6KB
- lc2020logov2a.gif (GRAPHIC) — 5KB
- 0000920148-25-000088.txt ( ) — 154KB
- lh-20250925.xsd (EX-101.SCH) — 2KB
- lh-20250925_lab.xml (EX-101.LAB) — 22KB
- lh-20250925_pre.xml (EX-101.PRE) — 12KB
- lh-20250925_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on September 25, 2025 that it will release its financial results for the third quarter of 2025 before the market opens on Tuesday, October 28, 2025, and will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website. A copy of the press release dated September 25, 2025 is furnished as Exhibit 99.1 hereto and incorporated by reference herein.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press release dated September 2 5 , 2025 issued by Labcorp Holdings Inc. Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABCORP HOLDINGS INC. Registrant Date: September 25, 2025 By: /s/ SANDRA D. VAN DER VAART Sandra D. van der Vaart Executive Vice President, Chief Legal Officer and Corporate Secretary